Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination-Reference-Cited by-同舟云学术

Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination

Published:2014-01-23 Issue:10 Volume:209 Page:1628-1634
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Wright Peter F.,Wieland-Alter Wendy,Ilyushina Natalia A.,Hoen Anne G.,Arita Minetaro,Boesch Austin W.,Ackerman Margaret E.,van der Avoort Harrie,Steven Oberste M.,Pallansch Mark A.,Burton Anthony H.,Jaffar Mohammad A.,Sutter Roland W.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/209/10/1628/13804313/jit671.pdf

Reference26 articles.

1. Emerging concept of poliomyelitis infection;Bodian;Science,1955

2. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review;Patriarca;Rev Infect Dis,1991

3. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination;Grassly;J Infect Dis,2010

4. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection;Ogra;N Engl J Med,1968

5. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines;Onorato;J Infect Dis,1991

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States;The Journal of Infectious Diseases;2024-05-29

2. Nutritional Status Link with Polioseronegativity Among Children from Poliomyelitis Transmission High-Risk Area of the Democratic Republic of the Congo (DRC);Journal of Multidisciplinary Healthcare;2024-03

3. Endemic Human Coronavirus-Specific Nasal Immunoglobulin A and Serum Immunoglobulin G Dynamics in Lower Respiratory Tract Infections;Vaccines;2024-01-17

4. Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China;The Lancet Regional Health - Western Pacific;2023-05

5. Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study;Vaccine;2023-03